Neudle.com: gait velocity

Differential
(Click to cross reference)

acanthocytosis

acral sensory symptoms

Addison's disease

Adies pupil

adrenomyeloneuropathy

adult polyglucosan body disease

adverse drug reaction

allodynia

alternating rapid movement

alternating rapid movement, impaired

ammonia

amyotrophic lateral sclerosis, differential diagnosis

ANA

anemia

angiography, cerebral, beaded vessels

angiography, cerebral

anti citrullinated antibody

anti MAG antibodies

anticonvulsants

anticonvulsants, untoward effects of

ataxia telangiectasia

auditory evoked brainstem potentials

autonomic dysfunction

basal ganglia, lesion of

basophilic stippling of red blood cells

bone marrow suppression

bradykinesia

brainstem, infarction of

cardiac arrest and resuscitation

CAT scan, emission, abnormal

cataracts

cauda equina

cauda equina, enhancement

cauda equina, lesion of

cerebellar ataxia, autosomal recessive

cerebellar ataxia, hereditary

cerebellar ataxia, neuropathy and vestibular areflexia syndrome

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar lesion

cerebellum, disease of

cerebrospinal fluid, abnormal

cerebrospinal fluid, drainage of

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, gold sol.curve of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, red cells in

cerebrospinal fluid, xanthochromia of

cerebrotendinous xanthomatosis

cerebrovascular accident

cerebrovascular accident, mimics

Charcot-Marie-Tooth

chest x-ray, abnormal

children

cholestanol

chorea

chromosomal abnormality

chromosome 17

Clinical Pathologic Conference(C.P.C.)

clubfoot as related to neurologic disease

cognition

coma

compression neuropathy

conduction block

confusion

congenital myopathy

congestive heart failure

corneal reflex, abnormal

corneal reflex, absent

cough

cranial nerve enhancement

cranial neuropathy

cranial neuropathy, multiple

C-reactive protein, elevated

creatine phosphokinase(CPK)elevated

deep gray nuclei

dementia

demyelinating disease

denervation potentials

diabetes mellitus, neurologic manifestations of

diabetic mononeuropathy

diarrhea

differential diagnosis

difficulty climbing stairs

digital health, wearable technology

diplopia

dissociated sensory loss

distal muscle atrophy

distal muscle weakness

electrocardiogram, abnormal

electroencephalogram, abnormalities of

electroencephalogram, inflammatory disease

electromyogram

electromyogram, decremental response

electron microscopy

encephalopathy

entrapment neuropathy

enzyme, defect

enzyme, muscle disease

eye movement, disorders of

face, numbness of

facial pain

facial weakness

facial weakness, bilateral

facioscapulohumeral syndrome

failed medical management

fine motor function, impaired

fingernails, abnormal

gammaglobulin therapy, intravenous

genetic neurologic disorders

genetic testing

glioma

Guillain Barre syndrome

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, infantile and childhood form

Guillain Barre syndrome, sensory

heavy metal intoxication

heralding manifestation

herpes simplex virus

herpes virus

herpes virus infection

Hodgkin's disease, neurologic involvement with

hot cross bun sign

hydrocephalus

hydrocephalus, normal pressure

hydrocephalus, treatment of

hypopigmentation of skin

immunoelectrophoresis, serum

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

inappropriate antidiuretic(A.D.H.)hormone

inclusion bodies

incoordination

industrial neurologic disorders

intellectual deficit

intellectual deterioration

intrinsic hand muscles, wasting of

Jakob-Creutzfeldt disease

jaw pain

Jewish

lactic dehydrogenase(LDH)

leg atrophy

leg numbness

leg weakness, bilateral

leg weakness, unilateral

lid closure, weakness of

liver disease

liver function enzymes

long bone lesion

lumbosacral plexopathy

memory, impairment of

meningeal enhancement

meningismus

mental status, abnormal

midbrain, atrophy

midbrain, infarction of

misdiagnosis

molecular genetics

monoclonal gammopathy

mononeuritis multiplex

mononeuropathy

mononeuropathy chronic inflammatory demyelinating

mononeuropathy, children

MRI, contrast enhanced

MRI, lumbosacral plexus

MRI, muscle

MRI, negative

MRI, peripheral nerve

MRI, spinal cord

multiple myeloma

muscle atrophy, progressive

muscle biopsy

muscle cramp

muscle hypertrophy

muscle hypertrophy, congenital

muscle weakness, proximal

muscular dystrophy

muscular dystrophy, facioscapulohumeral

myasthenia gravis

myasthenia gravis, late-onset

myasthenia gravis, misdiagnosis of

myasthenia gravis, presenting manifestations

myelin protein zero gene

myeloma, osteosclerotic

neoplasm, primary intracerebral

nerve biopsy

nerve conduction studies

nerve conduction studies, motor

nerve conduction studies, sensory

nerve enlargement

nerve hypertrophy

nerve root biopsy

nerve root enhancement

nerve root hypertrophy

neuritis, heavy metals causing

neuroendocrinology

neurogenic bladder

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neuromuscular disease, electrodiagnosis of

neuronopathy

neuronopathy, sensory

neuronopathy, sensory and motor

neuropathology, brain

neuropathy

neuropathy, chronic

neuropathy, demyelinating

neuropathy, hereditary peripheral

neuropathy, hypertrophic

neuropathy, motor

neuropathy, motor, multifocal

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, systemic

night blindness

numbness, extremity

numbness, generalized

nystagmus

occupational neuropathies

old age, neurology of

opportunistic infection

organomegaly

ornithine transcarbamylase deficiency

orthostatic hypotension

paraneoplastic ganglionopathy

paraparesis

paraparesis, spastic

paraproteinemia

parenteral alimentation

Parkinson disease, diagnosis

Parkinson disease, early symptoms

Parkinson disease, presymptomatic detection

peripheral blood smear

peripheral blood smear, abnormal

peroneal nerve

peroneal nerve palsy

peroneal nerve palsy, bilateral

peroneal nerve, lesion of

pes cavus

plasmacytoma

pleocytosis of cerebrospinal fluid

polyglucosan body disease

polymerase chain reaction

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, chronic inflammatory demyelinating, childhood

polyradiculoneuropathy

position sensation, abnormal

positional head-hanging test

posterior column disease

postoperative neurologic complications

prevention of neurologic disorders

prognosis

progressive neurologic disorder

proprioception

proprioception, abnormal

pruritus

pseudohypertrophy

psychological testing

pulmonary infiltrates

pupil

pupil, dilated and fixed, bilateral

pyramidal

pyramidal tract dysfunction

quadriceps atrophy

quadriparesis

quadriplegia

reading disorder, acquired

real-time quaking-induced conversion

remote effect of cancer on the nervous system

renal cell carcinoma

repetitive nerve stimulation

rheumatoid arthritis factor(R.A.factor)

rheumatoid arthritis, neurologic complications of

rheumatoid vasculitis

risk factors

rituximab

Romberg's sign

Sabin-Feldman dye test

saccadic eye movements, abnormal

sedimentation rate, elevated

sensory ganglia

sensory ganglia, abnormal

sensory loss

sensory loss, asymmetric

sensory loss, band distribution

sensory polyneuropathy

serum glutamic oxaloacetic transaminase

shooting pain

shoulder-girdle wasting

shunt procedure, ventricular

Sjogren's syndrome

skin, lesions in neurologic disorders

slurred speech

sodium valproate

sodium valproate, toxicity

somatosensory evoked potentials

spasticity

speech disorder

speech disorder, non aphasic

steroid therapy, CNS treatment and complications with

suspended sensory loss

sweating, abnormality of

temporalis muscle wasting

tongue, fasciculations of

toxoplasma complement fixation test

toxoplasmosis, acquired

toxoplasmosis, CNS

trauma

treatment of neurologic disorder

trigeminal nerve, abnormality of

turning slowly

urea-cycle enzymopathies

uremia

urinary incontinence

urine test in toxic screen

uveitis

varicella zoster virus

vascular endothelial growth factor

vibratory sensation, abnormal

voice, abnormality of

walking frame

walking, difficulty with

weakness

weakness, fatiguable

weakness, generalized

weakness, progressive

weight loss

wheelchair

whistle, inability to

Showing articles 800 to 850 of 2661 << Previous Next >>

The role of radiotracer imaging in Parkinson disease
Neurol 64:208-215, Ravina, B., et al, 2005

Amorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease
Neurol 64:392-393, Pot, C., et al, 2005

Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 352:1343-1356, Koller,H.,et al, 2005

Clinicopath Conf, Human Granulocytic Ehrlichiosis
NEJM 352:1358-1364, Case 10-2005, 2005

The Clinical and Genetic Spectrum of Spinocerebellar Ataxia 14
Neurol 64:1258-1260, Chen,D-H.,et al, 2005

Encephalopathy and Peripheral Neuropathy Following Diethylene Glycol Ingestion
Neurol 64:1273-1275, Hasbani,M.J.,et al, 2005

Cerebellar Ataxia and Central Nervous System Whipple Disease
Arch Neurol 62:618-620, Matthews,B.R.,et al, 2005

Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease
Arch Neurol 62:554-560,533, Anderson,V.C.,et al, 2005

Clinical and Electrophysiologic Correlates of IVIg Responsiveness in CIDP
Neurol 64:1471-1475, Iijima,M.,et al, 2005

Leukoencephalopathy with Ataxia, Hypodontia, and Hypomyelination
Neurol 64:1461-1464, Wolf,N.I.,et al, 2005

Does This Patient Have Myasthenia Gravis?
JAMA 293:1906-1914, Scherer,K.,et al, 2005

Autoantibodies to Folate Receptors in the Cerebral Folate Deficiency Syndrome
NEJM 352:1985-1991, Ramaekers,V.T.,et al, 2005

Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005

Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD
Neurol 64:1797-1798, Chung,K.A.,et al, 2005

[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005

Searching for a Relationship Between Manganese and Welding and Parkinsons Disease
Neurol 64:2021-2028, 2001, Jankovic,J., 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

New and Reliable MRI Diagnosis for Progressive Supranuclear Palsy
Neurol 64:2050-2055, Oba,H.,et al, 2005

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease
Arch Neurol 62:1290-1295, Tintner,R.,et al, 2005

Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease
Arch Neurol 62:1242-1248, Avorn,J.,et al, 2005

Camptocormia
Neurol 65:355-359, Azher,S.N. &Jankovic,J., 2005

Cervical Radiculopathy
NEJM 353:392-399, Carette,S. &Fehlings,M.G., 2005

Acute Painful Neuropathy in Thallium Poisoning
Neurol 65:302-304, Kuo,H.-C.,et al, 2005

Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005

Quantatative Assessment of Driving Performance in Parkinson's Disease
JNNP 76:176-180, 159, Wood, J.M., et al, 2005

Genetic Screening for a Single Common LRRK2 Mutation in Familial Parkinson's Disease
Lancet 365:410-412, Nichols, W.C., et al, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Acute Tetrodotoxin-Induced Neurotoxicity After Ingestion of Puffer Fish
Ann Neurol 57:339-348, 309, Kiernan, M.C., et al, 2005

West Nile Virus Presenting as Opsoclonus-myoclonus Cerebellar Ataxia
Neurol 64: 1095-1096, Khosla,J.S., et al, 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Clinicopath Conf, Prion Disease (Sporadic Creutzfeldt-Jakob Disease)
NEJM 353:1042-1050, Case 27-2005, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Science and Ethics of Sham Surgery, A Survey of Parkinson Disease Clinical Researchers
Arch Neurol 62:1357-1360,1343, Kim,S.Y.H.,et al, 2005

Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging, Probably Manganese Neurotoxicity
Arch Neurol 62:1385-1390, Klos,K.J.,et al, 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Neuropathology of Dementia in Parkinsons Disease: A Prospective, Community-Based Study
Ann Neurol 58:773-776,663, Aarsland,D.,et al, 2005

Levodopa and the Progression of Parkinson's Disease
NEJM 351:2498-2508, The Parkinson Study Group, 2004

Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004

Poststroke "Pushing", Natural History and Relationship to Motor and Functional Recovery
Stroke 35:2873-2878, Danells,C.J.,et al, 2004

Correlation Between Antemortem Magnetic Resonance Imaging Findings and Pathologically Confirmed Corticobasal Degeneration
Arch Neurol 61:1881-1884, Josephs,K.A.,et al, 2004

The Parkinsonian Phenotype of Spinocerebellar Ataxia Type 2
Arch Neurol 61:35-38, Lu,C.,et al, 2004

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004

Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004

Ophthalmologic Features of Parkinson's Disease
Neurol 62:177-180, Biousse,V.,et al, 2004

Effect of Levodopa Treatment for Parkinsonism in Welders
Neurol 62:730-733, Koller,W.C.,et al, 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004

Clinicopath Conf., Small-Fiber Neuropathy
NEJM 350:2181-2189, Case 16-2004, 2004

Parkinson's Disease
Lancet 363:1783-1793, Samii,A.,et al, 2004

Showing articles 800 to 850 of 2661 << Previous Next >>